Renaissance Technologies
CBST

Renaissance Technologies’s CUBIST PHARMACEUTICALS INC CBST Stock Holding History

Renaissance Technologies’s Portfolio CBST Stock Details CBST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-47,420
Closed -$3.31M – 3137
2014
Q2 		$3.31M Sell
47,420
-141,671
-75% -$9.64M 0.01% 1461
2014
Q1 		$13.8M Buy
189,091
+63,171
+50% +$4.71M 0.03% 684
2013
Q4 		$8.67M Sell
125,920
-198,700
-61% -$12.9M 0.02% 874
2013
Q3 		$20.6M Sell
324,620
-137,600
-30% -$8.32M 0.05% 462
2013
Q2 		$22.3M Buy
+462,220
New +$22.7M 0.06% 407

Other funds holding CBST

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Renaissance Technologies's CBST Position: Q3 2014 in Review

Renaissance Technologies sold out of CUBIST PHARMACEUTICALS INC (CBST) in Q3 2014, closing a stake of 47,420 shares — an estimated $3.31M sold.

Renaissance Technologies first reported a position in CBST in Q2 2013 and held it in 5 quarters. The position peaked at $22.3M in Q2 2013. 254 funds tracked by Wall St. Rank hold CBST as of Q3 2014.

  • Renaissance Technologies reported no remaining CUBIST PHARMACEUTICALS INC position as of Q3 2014 after selling out during the quarter.
  • Renaissance Technologies sold 47,420 CUBIST PHARMACEUTICALS INC shares in Q3 2014, an estimated $3.31M.
  • Renaissance Technologies first reported a position in CUBIST PHARMACEUTICALS INC in Q2 2013 and held it in 5 quarters.
  • Renaissance Technologies's CUBIST PHARMACEUTICALS INC position peaked at $22.3M in Q2 2013.
  • 254 funds tracked by Wall St. Rank held CUBIST PHARMACEUTICALS INC as of Q3 2014.

Based on Renaissance Technologies's 13F filing for Q3 2014, filed 12 Nov 2014.